Marie Elizabeth Perrone, MD
Pathology · Portland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Pacific Pathology Associates Inc · 16 clinicians in this group
Looking this up.
Hospitals listed: Legacy Emanuel Medical Center · Legacy Good Samaritan Medical Center · Legacy Meridian Park Medical Center · Legacy Mount Hood Medical Center · Legacy Salmon Creek Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Perrone’s office at (503) 561-5350 to ask if they take your plan before you enroll.
California Medical Board record
Licence A167776 · Delinquent
Licence status: Delinquent · since 2020 · expires 2022-02-28 · University of Chicago, Pritzker School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MDRE.ML.60658126Physician And Surgeon Residency Limited License · since 2016 · expires 2018-07-13ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Legacy Emanuel Medical CenterPortland, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Legacy Health, which runs 7 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 220.63 (174.43 to 266.84) · 79 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.401, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.45, Oct 2024 – Sep 2025
- Legacy Good Samaritan Medical CenterPortland, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Legacy Health, which runs 7 hospitals in 2 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.311, Oct 2024 – Sep 2025
- Legacy Meridian Park Medical CenterTualatin, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Legacy Health, which runs 7 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Legacy Mount Hood Medical CenterGresham, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Legacy Health, which runs 7 hospitals in 2 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.318, Oct 2024 – Sep 2025
- Legacy Salmon Creek Medical CenterVancouver, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Legacy Health, which runs 7 hospitals in 2 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
See every measure and the patient survey for Legacy Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 220.63 (174.43 to 266.84) · 79 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.401 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.45 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.96) · 426 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.77 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.2 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 285 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.4 (0.18 to 0.61) · 3,393 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 3,343 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.64 (0.62 to 4.65) · 1,262 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.09 (0.55 to 3.64) · 443 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.84 to 3.71) · 1,240 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (2.41 to 15.68) · 449 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.48 (1.68 to 9.29) · 438 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.94 (0.26 to 1.63) · 2,977 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.927 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.845 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.86 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 209 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 332 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 18.2 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 56.4 · 86 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.6) · 80 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.7) · 166 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Legacy Good Samaritan Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.311 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.25 to 2.1) · 953 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.63 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.64 (143.38 to 253.9) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 90 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 1,687 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.07 to 0.5) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.88 (0.77 to 4.98) · 1,072 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0 to 3.05) · 472 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.94 (0.46 to 3.42) · 1,031 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.89 (1.84 to 15.95) · 499 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.59 to 8.39) · 514 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.87 (0.43 to 3.32) · 408 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0 to 1.47) · 2,398 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 51 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.556 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.901 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.972 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 139 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.7 · 90 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 166 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 11.4 · 122 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 253 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 60 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.1 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.4 to 16.9) · 259 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 518 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,131 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Legacy Meridian Park Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 1 better, 6 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.13 to 2.13) · 578 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.55 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 205.52 (145.95 to 265.09) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.6 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 196 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 2,263 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 3,119 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.74 (1.46 to 6.01) · 751 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.01 (0.33 to 3.69) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 722 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.49 (2.02 to 18.95) · 344 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.09 (1.15 to 9.03) · 315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.01 (0.51 to 3.5) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.15) · 2,368 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.526 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.965 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.068 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 145 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -24.5 · 62 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.2 · 231 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.7 · 188 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 413 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 104 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.4) · 710 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 514 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,185 patients answered, 32% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Legacy Mount Hood Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.318 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 359 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.74 to 1.59) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 157 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.9 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,147 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,662 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,692 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.24 (2.79 to 7.69) · 287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 274 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.78 (0 to 17.06) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (0.64 to 8.94) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.06 (0.55 to 3.58) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.15 to 2.12) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.432 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.075 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 55 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 363 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6.2 · 169 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 0.9 · 110 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.6 · 254 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.1 to 16) · 738 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 252 cases | No different | Jan 2024 – Dec 2024 |
What patients said (815 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Legacy Salmon Creek Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.84 (0 to 1.81) · 756 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.82 to 1.52) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 160.37 (98.38 to 222.35) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.4 · 338 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 2,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.07 to 0.5) · 3,925 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 3,911 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.24 to 5.59) · 887 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 266 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.15 (0.59 to 3.71) · 843 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.16 (3.35 to 18.96) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (1.44 to 8.55) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.14 to 3.05) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.39 to 1.9) · 3,201 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 62 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.627 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.175 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.423 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 183 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 661 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.9 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 12 · 377 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -41.6 · 265 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 498 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (3 to 6.5) · 201 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (7.2 to 13) · 201 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 71 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 526 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,092 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$72,386
Medicare paid this office $72,386 for 749 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 139 | $14,658 | $53 |
| Pathology examination of tissue using a microscope, intermediate complexity | 279 | $14,217 | $29 |
| Cell examination of specimen, selective cellular enhancement technique | 114 | $7,003 | $56 |
| Evaluation of fine needle aspirate with interpretation and report | 74 | $6,289 | $56 |
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $4,451 | $22 |
See all 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 139 | $14,658 | $53 |
| Pathology examination of tissue using a microscope, intermediate complexity | 279 | $14,217 | $29 |
| Cell examination of specimen, selective cellular enhancement technique | 114 | $7,003 | $56 |
| Evaluation of fine needle aspirate with interpretation and report | 74 | $6,289 | $56 |
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $4,451 | $22 |
| Cell examination of specimen, selective cellular enhancement technique | 114 | $3,040 | $22 |
| Evaluation of fine needle aspirate | 68 | $2,756 | $28 |
| Special stained specimen slides to examine tissue, initial procedure | 74 | $2,342 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 18 | $2,100 | $87 |
| Pathology examination of tissue using a microscope, moderately high complexity | 18 | $1,432 | $65 |
| Protein measurement, serum | 77 | $1,024 | $13 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 18 | $693 | $17 |
| Immunologic analysis technique on serum (immunofixation) | 51 | $655 | $12 |
| Pathology examination of tissue using a microscope, moderately low complexity | 27 | $262 | $9 |
| Special stained specimen slides to examine tissue including interpretation and report | 12 | $221 | $10 |
| Protein measurement, serum | 13 | $199 | $14 |
| Immunologic analysis technique on serum (immunofixation) | 11 | $171 | $14 |
| Protein measurement, body fluid | 12 | $128 | $11 |
Who their Medicare patients are
749 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 10% · Women 51% · Also on Medicaid 14% · Health risk score 1.44. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 72% · Cancer 29% · Diabetes 28% · Chronic kidney disease 27% · Coronary heart disease 25% · Heart failure 20% · Atrial fibrillation 19% · Depression 19% · COPD 16% · Stroke 9% · Dementia 6%.
The office billed $275,680, Medicare allowed $92,678 and paid $72,386; for 1,997 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 749 | 1,997 | 74 | 1.44 | $275,680 | $72,386 |
| 2023 | 779 | 1,930 | 73 | 1.51 | $251,430 | $67,002 |
| 2022 | 735 | 1,795 | 73 | 1.46 | $249,645 | $67,578 |
| 2021 | 305 | 630 | 73 | 1.46 | $91,041 | $24,488 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 155 | $14,853 | $52 |
| Pathology examination of tissue using a microscope, intermediate complexity | 214 | $9,350 | $28 |
| Cell examination of specimen, selective cellular enhancement technique | 142 | $8,410 | $54 |
| Evaluation of fine needle aspirate with interpretation and report | 85 | $7,643 | $55 |
| Cell examination of specimen, selective cellular enhancement technique | 168 | $4,388 | $22 |
| Special stained specimen slides to examine tissue, each additional procedure | 43 | $3,722 | $22 |
| Evaluation of fine needle aspirate | 74 | $3,287 | $28 |
| Evaluation of fine needle aspirate with interpretation and report | 13 | $1,760 | $135 |
| Special stained specimen slides to examine tissue, initial procedure | 50 | $1,524 | $27 |
| Protein measurement, serum | 95 | $1,355 | $14 |
| Immunologic analysis technique on serum (immunofixation) | 68 | $1,000 | $14 |
| Special stained specimen slides to identify organisms including interpretation and report | 25 | $697 | $20 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 21 | $639 | $17 |
| Special stained specimen slides to examine tissue including interpretation and report | 28 | $605 | $9 |
| Pathology examination of tissue using a microscope, moderately low complexity | 26 | $235 | $8 |
| Protein measurement, serum | 12 | $171 | $14 |
| Protein measurement, body fluid | 11 | $131 | $12 |
2022: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 146 | $13,255 | $51 |
| Pathology examination of tissue using a microscope, intermediate complexity | 196 | $9,256 | $30 |
| Evaluation of fine needle aspirate with interpretation and report | 90 | $8,216 | $56 |
| Cell examination of specimen, selective cellular enhancement technique | 146 | $8,070 | $53 |
| Cell examination of specimen, selective cellular enhancement technique | 167 | $4,719 | $22 |
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $3,409 | $22 |
| Evaluation of fine needle aspirate | 66 | $2,777 | $29 |
| Evaluation of fine needle aspirate with interpretation and report | 15 | $2,500 | $132 |
| Special stained specimen slides to examine tissue, initial procedure | 64 | $1,981 | $28 |
| Special stained specimen slides to examine tissue, initial procedure | 19 | $1,635 | $78 |
| Pathology examination of tissue using a microscope, moderately high complexity | 12 | $794 | $66 |
| Protein measurement, serum | 48 | $687 | $14 |
| Special stained specimen slides to identify organisms including interpretation and report | 25 | $671 | $21 |
| Immunologic analysis technique on serum (immunofixation) | 32 | $453 | $14 |
| Special stained specimen slides to examine tissue including interpretation and report | 22 | $448 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 11 | $340 | $31 |
| Protein measurement, body fluid | 15 | $211 | $14 |
| Pathology examination of tissue using a microscope, moderately low complexity | 21 | $210 | $9 |
2021: 11 services
| Cell examination of specimen, selective cellular enhancement technique | 93 | $5,436 | $56 |
| Pathology examination of tissue using a microscope, intermediate complexity | 31 | $4,028 | $54 |
| Pathology examination of tissue using a microscope, intermediate complexity | 83 | $3,851 | $31 |
| Evaluation of fine needle aspirate with interpretation and report | 32 | $3,093 | $58 |
| Cell examination of specimen, selective cellular enhancement technique | 74 | $1,972 | $23 |
| Special stained specimen slides to examine tissue, each additional procedure | 17 | $1,083 | $24 |
| Pathology examination of tissue using a microscope, moderately high complexity | 11 | $878 | $68 |
| Special stained specimen slides to examine tissue, initial procedure | 26 | $780 | $29 |
| Evaluation of fine needle aspirate | 19 | $681 | $30 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $375 | $22 |
| Pathology examination of tissue using a microscope, moderately low complexity | 14 | $130 | $9 |
Medicaid work
$10,680 in 2024
Medicaid paid $10,680 for 444 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 357 | $10,353 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 75 | $294 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $33 |
| 2024 | 444 | 3 | 69 | $10,680 |
| 2023 | 897 | 5 | 76 | $32,845 |
| 2022 | 744 | 3 | 47 | $22,511 |
| 2021 | 299 | 4 | 33 | $3,111 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 604 | $25,407 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 248 | $5,063 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $1,233 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 18 | $975 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $167 |
2022
| TISSUE EXAM BY PATHOLOGIST | 472 | $17,678 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 258 | $4,186 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 14 | $648 |
2021
| TISSUE EXAM BY PATHOLOGIST | 139 | $2,332 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 126 | $600 |
| TISSUE EXAM BY PATHOLOGIST | 14 | $179 |
| TISSUE EXAM BY PATHOLOGIST | 20 | $0 |
Money from drug and device companies
$143 in 2021
| 2021 | 1 | 1 | None | $143 |
| 2019 | 1 | 1 | None | $86 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gen-Probe Sales & Service | Aptima | $143 | 1 payment
|
See the published payment
| Gen-Probe Sales & Service | Meals · 2021-07-22 | Aptima | $143 |
See earlier years (2019)
2019: $86
| AstraZeneca Pharmaceuticals LP | Imfinzi | $86 | 1 payment
|
Professional record
- NPI
- 1780048876
- Licence
- CA A167776, WA ML60658126California A167776: Delinquent · expires 2022-02-28Washington MDRE.ML.60658126: Expired
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 300 Pasteur Drive, Room L235, Mc:5324, Stanford, CA, 94305
- NPI first listed
- 2016-04-05
- NPI last updated
- 2026-04-17
- NPI record certified
- 2026-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Drive, Room L235, Mc:5324, Stanford, CA, 94305